(Q48647924)

13 February 2018

title

Intrathecal allograft of chromaffin cells for intractable pain treatment: a model for understanding CNS tolerance mechanisms in humans. (English)

1 reference

13 February 2018

author name string

Tkaczuk J

1

1 reference

13 February 2018

Bes JC

2

1 reference

13 February 2018

de Bouet du Portal H

3

1 reference

13 February 2018

Tafani M

4

1 reference

13 February 2018

Duplan H

5

1 reference

13 February 2018

Abbal M

6

1 reference

13 February 2018

Lazorthes Y

7

1 reference

13 February 2018

Ohayon E

8

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

13 February 2018

Transplantation Proceedings

published in

1 reference

13 February 2018

volume

29

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

2356-2357

1 reference

13 February 2018

Update on cellular transplantation into the CNS as a novel therapy for chronic pain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Transforming growth factor-beta in neural embryogenesis and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Transforming growth factor-beta 1 (TGF-β1) expression and regulation in rat cortical astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2897%2900401-6

7 January 2021

10.1016/S0041-1345(97)00401-6

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9270762

1 reference

13 February 2018